Rx IP Update - April 2019

Published date03 May 2019
Subject MatterLabeling,Appeals,Prescription Drugs,Biosimilars,Generic Drugs,Public Comment,Proposed Amendments,Drug Safety,Canada,Conflicts of Laws,Patent Invalidity,Health Canada,Online Sales Bans,PMNOC Regulations,Patented Medicine Prices Review Board (PMPRB),Certificates of Supplementary Protection (CSPs),Food and Drug Act
AuthorNancy Pei,Abigail Smith,Urszula Wojtyra,Katie Lee,Brandon Heard,Tierney GB Deluzio
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT